Shahid Islam profile picture

Contact Information

Shahid Islam, MD, PhD, FRCPC, FCAP
613-737-8899, 78297
sislam@toh.on.ca

Office Address: Department of Pathology and Laboratory Medicine
The University of Ottawa
501 Smyth Road, Ottawa, ON K1H 8L6
Telephone: 613-737-8899 ext. 78297
Fax: 613-737-8853
Email: sislam@ottawahospital.on.ca

Shahid Islam

Clinician Investigator, Cancer Therapeutics Program
Ottawa Hospital Research Institute

Research Interests

Clinical Interest:

Breast and Gynecologic Oncologic Surgical Pathology
Cytopathology

Brief Biography

Dr. Islam migrated to Ottawa, Ontario in 2004 and ever since then; has been with the Ottawa Hospital. Currently, he is a permanent full-time senior staff physician in the division of Anatomical and Surgical Pathology in the department of Pathology and Laboratory Medicine at the Ottawa Hospital of the Eastern Ontario Regional Laboratory Association (EORLA) and an Associate Professor in the Faculty of Medicine at the University of Ottawa. Prior to this, Dr. Islam was the Deputy Head and Site Chief of the division of Anatomical Pathology at the Ottawa Hospital for 5 years (2007-2012). As the Deputy Head and Site Chief, he was a member of the Anatomical and Surgical Pathology Executive Committee (2007-2012) and Committee for Quality Improvement for Anatomical Pathology at the Ottawa Hospital (2005-2012).

Dr. Islam is currently the Director of the Anatomical Pathology Residency Training Program at the University of Ottawa for the Royal College of Physicians and Surgeons of Canada (2011-2021) and is  responsible for providing an organized educational program with guidance and supervision of the resident, facilitating the resident’s ethical, professional, and personal development while ensuring safe and appropriate care for patients. This includes selecting and supervising the faculty and other program personnel at each participating institution, appointing a local site director, and monitoring appropriate resident supervision at all participating institutions. Under his direction, the residency program has undergone transformational change and is fully accredited by the Royal College of Physicians and Surgeons of Canada and offers exemplary and high quality contents with in-house 15 residents. Dr. Islam is one of the founding members of the Specialty Committee for Anatomical Pathology at the RCPSC for creating document suits for the CBD model and the Lead for implementing Competency by Design (CBD) Model of residency training at the University of Ottawa.

The uOttawa program in Anatomical Pathology is now well organized into basic clinical year, Transition to discipline (PGY1), foundational year (PGY2), core year (PGY3-4) and transition to practice year (PGY5) in accordance to the Competency by design (CBD) model of the Royal College. Under the guidance of Dr. Islam, the program has developed a very comprehensive program website at https://med.uottawa.ca/pathology/education/postgraduate-medical-education/anatomical-pathology which hosts all the important information and documents about the program and its transition to CBD model. This has led to national and international visibility and recognition of the program and the world -class training that it offers.

As Founder Member and Vice-Chair, Area of Focused Competency (AFC) in Cytopathology, Royal College of Physicians and Surgeons of Canada (RCPSC) (2012-2019), Dr. Islam was responsible creating the key and enabling competencies, portfolio, assessment tools, accreditation standards and application form as part of the Working Group at the RCPSC consisting of cytopathologists from various key pathology programs in Canada, many already offering Cytopathology fellowships.

The Working Group transitioned into the official RCPSC AFC (Area of Focused Competency) Committee for Cytopathology in 2014 and Dr. Islam became the Vice-Chair and was responsible for reviewing university applications for accreditation as well as examining the Practice Eligibility Route for the AFC in Cytopathology as part of committee members.

Currently Dr. Islam is the Chair-elect/Chair, RCPSC AFC Committee in Cytopathology, (2019-2020, 2020-2023). As Chair, Dr. Islam is responsible for:      
1. advising the parent specialty committee on matters including review of diploma status, and review of applications for recognition of a new discipline;      
2. advising the parent specialty committee on matters relating to the assessment of individual credentials;      
3. advising the Royal College on matters including the basic accreditation requirements, applications for accreditation of new programs, assessment of pre-survey questionnaires and recommendation of accreditation status;      
4.  advising the Credentials Committee on matters of the portfolio, assessment of individual credentials, and oversight of the assessor pool;      
5.  advising other committees of the Royal College such as the Executive Committee, regional advisory committees and the Biomedical Ethics Committee on matters relevant to the discipline;      
6.  liaising with the national specialty society (NSS) on educational issues and collaborate to ensure the sustained health of the discipline.

Dr. Islam is also a senior member of the Postgraduate Residency Accreditation Team and the Postgraduate Education Committee at the University of Ottawa.

Dr. Islam’s scientific works have been presented at many international meetings and conferences.

In his earlier years, Dr. Islam’s clinical and research work was profiled in Science, published by the American Association for the Advancement of Science titled ‘Shahidul Islam: Balancing Patient Care and Research” at http://sciencecareers.sciencemag.org/career_magazine/previous_issues/articles/2003_10_17/nodoi.14310383684975961938
During that time Dr. Islam was working as a clinical fellow at the University of Texas Medical Centre at Dallas, Dallas, Texas, USA.

Selected Publications

Peer Reviewed Published Manuscripts, Commentaries and Practice Guidelines (71):   
1.            Combination of MCM2 With Ki67 and p16 Immunohistochemistry Can Distinguish Uterine Leiomyosarcomas.  Keyhanian, Kianoosh ; Lage, Janice M. ; Chernetsova, Elizaveta ; Sekhon, Harman; Eslami; Zohreh, Islam, Shahidul . International Journal of Gynecological Pathology: June 05, 2019 - Volume Publish Ahead of Print - Issue - p doi: 10.1097/PGP.0000000000000616      
2.            IFITM1 outperforms CD10 in differentiating low grade endometrial stromal sarcomas from smooth muscle neoplasms of the uterus. Aurelia Busca, Carlos Parra-Herran, Previn Gulavita, Shahidul Islam. International Journal of Gynecological Pathology, Volume 37, Number 4, July 2018, pp. 372-378(7)      
3.            Pathology Perspective on Gynecologic Malignancy Screening Questions Asked Through an Electronic Consultation Service. Carol Wang, Clare Liddy, Shahidul Islam, Amir Afkham, Fady Shehata, Glenn Posner, Erin Keely. 2018, LABORATORY INVESTIGATION, Volume 98, Pages, 601-601      
4.            Pathology Cancer Clinic—An Innovative Model to Enhance the Quality of Patient Care for Women With Gynecologic Cancer at The Ottawa Hospital. Osama Khan, Anthea Lafreniere, George Gray, Stephanie Pietkiewicz, Kona Williams, Tien Le, Stephanie Petkiewicz, Laura Hopkins, Shahidul Islam. 2018, American Journal of Clinical Pathology, Volume 150 Issue, suppl_1      
5.            FNA neck mass; 48-year old male. Shahidul Islam, Zeina Ghorab, Michele Weir, Anne Ecobichon-Morris, Susan McRae. January, 2018      
6.            Histomorphological Changes in Endometriosis in a patient treated with Ulipristal: A Case Report. Justin Batemen and Shahidul Islam. Pathology - Research and Practice Volume 213, Issue 1, January 2017, Pages 79-81      
7.            https://iqmh.org/Portals/0/Docs/Services/eLearn_Labs/e-Learn%20LAB%20-%20CYTO%201801.pdf      
8.            Anal pap 47-year-old male; HIV-seropositive. Zeina Ghorab, Shahidul Islam, Michele Weir, Susan McRae and Anne Ecobichon-Morris. January, 2017 https://iqmh.org/Portals/0/Docs/Services/eLearn_Labs/e-Learn%20LAB%20-%20CYTO%201701.pdf      
9.            Architectural Overlap between Benign Endocervix and Pattern A Invasive Endocervical Adenocarcinoma: Are All Pattern A Adenocarcinomas Really Invasive? Greg Douglas, Brooke E Howitt, John Schoolmeester, Lauren Schwartz, Zuzana Kos, Shahidul Islam, Bojana Djordjevic, Carlos Parra-Herran. Pathol Res Pract. 2017 Jul;213(7):799-803. doi: 10.1016/j.prp.2017.03.008. Epub 2017 Mar 8.  
10.            Pap, liquid-based 42-year old female. Michele Weir, Zeina Ghorab, Shahidul Islam, Ms. Anne Ecobichon-Morris, Susan McRae. May, 2017 https://iqmh.org/Portals/0/Docs/Services/eLearn_Labs/e-Learn%20LAB%20-%20CYTO%201705.pdf  
11.            Nuclear immunohistochemical IKK-εexpression in flat epithelial atypia (FEA) of the breast: A predictor of ipsilateral ADH, in-situ or invasive malignancy? PA Williams, CE Parra-Herran, Y Ayroud, S Islam, DH Gravel, SJ Robertson, C Pratt, Cancer Research, 2015, Volume,76, Issue, 4 Supplement Pages, P1-01-11-P1-01-11   12.            Pathologist Goes to Work: Affordable Automation of Cervical Cancer Screening in Developing Countries. S El Hallani, H El Attar, D Garner, CE Marginean, S Islam, H Sekhon. 2014, LABORATORY INVESTIGATION Volume  94, Pages, 101A-101A  
13.            GATA-3 expression is not associated with complete pathological response in triple negative breast cancer patients treated with neoadjuvant chemotherapy.  J. K. Wasserman, P. A. Williams, S. Islam, S. J. Robertson.  Pathology - Research and Practice Volume 212, Issue 6, June 2016, Pages 539-544  
14.            Expectant Management of Incidental Endometrial Carcinoma in First Trimester – Case Report and Discussion. L. Saciragic,  C. Ball, S. Islam, M. Fung Kee Fung.  J Obstet Gynaecol Can 2014;36(11):1010–1013. 2014  
15.            Nuclear H&E Staining Pattern in Flat Epithelial Atypia of the Breast Predicts Presence of Carcinoma on Excision: A Digital Image Based Histopathologic Analysis. PA Williams, B Djordjevic, Y Ayroud, S Islam, D Gravel, CE Parra-Herran. 2014, LABORATORY INVESTIGATION, Volume 94, Pages, 89A-89A  
16.            Three-dimensional cell groups with disordered nuclei and cellular discohesion (3DDD) are associated with high sensitivity and specificity for cystoscopic urine cytopathological diagnosis of low-grade urothelial neoplasia. Mai KT, Ball CG, Kos Z, Belanger EC, Islam S, Sekhon H. Diagn Cytopathol. 2014 Jul;42(7):555-63. doi: 10.1002/dc.23069. Epub 2013 Nov 23.  
17.            Teaching the Can MEDS Roles to Laboratory Medicine Residents: Residents as Teachers and Development of ePortfolios. S. Strickland and S. Islam. Canadian Journal of Pathology, volume 6, Issue 3, pg 80, 2014  
18.            An Historical Step for Advanced Cytopathology Training in Canada. S. Islam, M. Wier and M. Auger. Cancer Cytopath Volume123, Issue1 January 2015   19.            Nuclear Morphometry in Flat Epithelial Atypia of the Breast as a Predictor of Malignancy-A Digital Image-based Histopathologic Analysis.  Williams PA, Djordjevic B, Ayroud Y, Islam S, Gravel D, Robertson SJ, Parra-Herran C. Anal Quant Cytopathol Histpathol. 2014 Dec;36(6):305-13.  
20.            Frequency of Malignancy at Final Excision in Biopsy-diagnosed Benign Papillary Lesions of the Breast. Petkiewitz, S and Islam, S. Can J Pathol Can J Pathol 2013;5(3):117–8.  
21.            Multifocal Flat Epithelial Atypia: Possible Precursor of Breast Carcinoma. MS Amin, M Hassan, SJ Robertson, S Islam. 2013, LABORATORY INVESTIGATION, Volume 93, Pages, 27A-27A  
22.            Co-expression and cellular localization of p16 (INK 4a) and Mib1 (Ki-67) help in differentiating high grade squamous intraepithelial lesions from immature squamous metaplasia of the uterine cervix. Amin MS, Senterman M, Islam S. Can J Pathol, Vol 3, Issue 4, 2012  
23.            Breast cancer 1 (BRCA1) protein expression as a prognostic marker in sporadic epithelial ovarian carcinoma: an NCIC CTG OV.16 correlative study. Weberpals JI, Tu D, Squire JA, Amin MS, Islam S, Pelletier LB, O'Brien AM, Hoskins PJ, Eisenhauer EA. Annals of Oncology, Volume 22, Issue 11, November 2011, Pages 2403–2410, https://doi.org/10.1093/annonc/mdq770  
24.            Cadherin-catenin Protein Expression Profile in Ovarian Neoplasms. S Amin and S. Islam. European Journal of Cancer 48(6):64 · November 2012, DOI: 10.1016/S0959-8049(12)72010-5  
25.            Repression of cancer cell senescence by PKCi. Paget JA, Restall IJ, Daneshmand M, Mersereau JA, Simard M, Parolin DAE, Lavictoire S J, Amin MS, Islam S, Lorimer IAJ.  Oncogene volume 31, pages 3584–3596 (02 August 2012)   26.            Cytologic Features of Thyroid Lesions Diagnosed as Indeterminate for Neoplasia Which Predict Follicular Neoplasm on Fine Needle Aspiration Biopsy of Thyroid (FNAB): A 5-Year Retrospective Study in a Tertiary Care Hospital in Ontario, Canada. IT Ahmed, KT Mai, S Islam. 2010, LABORATORY INVESTIGATION, Volume 90, Pages, 85A-86A  
27.            Immunocytochemical study of urine cytological preparations from secondary prostatic adenocarcinoma involving the urinary bladder. K. T. Mai, Ahmed Itrat, S. J. Robertson, E. C. Belanger, J. Veinot and S. Islam.  Diagnostic Cytopathology, vol 36, #10, pg 715  
28.            Atypical Squamous Cells, Cannot Exclude High Grade Squamous Intraepithelial Lesion, ASC-H: Cytohisto correlation and Diagnostic Pitfalls. G. Mokhtar, N. Dilatour, A. Assiri, M. Gilliat, M. Senterman and S. Islam . Acta Cytol. Vol 52: 169–177  
29.            Cytologic features of benign solitary pulmonary nodules with radiologic correlation and diagnostic pitfalls: a report of six cases. Shahidul Islam, NL Delatour Roustan, Shafeeq R Salahdeen, Kien T Mai, Mary Senterman, Ghadeer A Mokhtar. 2009, Acta cytological, Volume 53 Issue 2, Pages 201-210  
30.            Immuncytochemical study of the urine cytological preparations of the secondary prostatic adenocarcinoma of the urinary bladder. IT Ahmed, HQ Al-Moghrabi, S Islam, EC Marginean, KT Mai. 2008, LABORATORY INVESTIGATION, Volume 88, Pages, 67A-68A  
 31.            Progesterone Receptor in Renal Oncocytoma and Chromophobe Renal Cell Carcinoma. K. T. Mai, I. Teo, E. C. Belanger, S. Robertson, E. C. Marginean and S. Islam. Histopathology. 2008 Feb; 52(3): 277-82.  
32.            Differential Expression of Cadherin-catenin Complex In Malignant Mesothelioma And Lung Adenocarcinoma.  Mitra Nabavi, Shahidul Islam. 2007/5/1, Pathology International, Volume 57, Pages, A33-A34  
33.            Differential expression profile of cadherins in thyroid neoplasm: localization of cadherin-11 with co-expression of e and N-cadherins by immunohistochemistry in the diagnosis of papillary thyroid cancer. Mitra Nabavi, Shahidul Islam. 2007, Pathology International, Volume, 57, Pages, A27-A28  
34.            Differential expression of cadherin and catenin in prostatic adenocarcinoma. Hatim Al-Moghraby, Shahidul Islam. 2006, MODERN PATHOLOGY, Volume 19, Pages,76-76  
35.            Fine Needle Aspiration of Biopsy for Pre-operative work of Pancreatic Cystic Neoplasm: Report of 4 cases. N. R. Delatour, M. C. Policarpio-Nicolas, H. Yazdi, S. Islam. Acta Cytol, vol 51: 925-933  
36.            Reprocessing of Unsatisfactory Thin Prep Specimens Increases Specimen Adequacy and Detection of Significant Abnormal Cervicovaginal Lesions. S. Islam, A. M. West, H. Saboorian and R. Ashfaq 2004. Cancer. 25; 102(2): 67-73  
37.            Fine Needle Aspiration of Collecting Duct Carcinoma of The Kidney: Distinctive features and Differential Diagnosis. V. R. Sarode, S. Islam, D. Wooten, K. Molberg and R. Ashfaq 2004. Acta Cytol. 48(6): 843-8  
38.            An Illiac Mass in a 25-Year-Old woman (a case of Osteochondroma and literature review). S. Islam, J. Bennett, B. Parkin and A. Zaher. Arch Path and Lab Med. 127(8): e355-6  
39.            A Case of Tophaceous Gout: Nodulocystic lesion on the Finger. Islam S and Zaher A. ASCP. Surg. Path II. Vol 27, no 3, ISSN-1091-8663  
40.            Urinary Obstruction in a 78- Year-Old-woman with A Pelvic Mass (a case of Brenner Tumor and literature review). G. Gannon, S. Islam, R. Conley and A. Zaher .Arch Path and Lab Med. Vol 127  
41.            A 29-Year-Old Male with Intermittent Lower Leg Pain. (A case of Ewing Sarcoma and literature review). S. Islam, R. Conley and A. Zaher. Arch Path and Lab Med. Vol 1271.  
42.            Fine Needle Aspiration of Biopsy for Pre-operative work of Pancreatic Cystic Neoplasm: Report of 4 cases. N. R. Delatour, M. C. Policarpio-Nicolas, H. Yazdi, S. Islam. Acta Cytol, vol 51: 925-933  
43.            A 30-Year-Old-Man with Recurrent Pneumonia (a case of Lung Sequestration and literature review). L. Shope, S. Islam and A. Zaher. Arch Path and Lab Med. Vol 126  
44.            A 48-Year-Old White Woman with a Nodular Mass in the Right Parotid Gland (a case of Malignant Lymphoma in Parotid Gland and literature review). T. Sheridan, S. Islam, and A. Zaher . Arch Path and Lab Med. Vol 125  
45.            Deep Venous Thrombosis in a 21- Year-Old Woman with a Retroperitoneal Mass (a case of Malignant Peripheral Nerve Sheath Tumor and literature review). G. Gelickman, S. Islam, and A. Zaher. Arch Path and Lab Med. Vol 124, 8  
46.            A Case of Systemic Mastocytositosis (literature review). Islam, S., and Zaher, A. Arch. Path and Lab Med. Vol 124  
47.            Expression of vimentin in squamous cell carcinoma: Relationship with phenotypic changes and cadherin based cell adhesion. Islam, S., Wheelock, M. J., and Johnson, K. R. J. Cell. Biochm, 78:141-150  
48.            N-cadherin extracellular repeat 4 mediates epithelial to mesenchymal transition and increased motility. Jae-Kim, Islam, S., Young J. Kim, Ryan S. Prudoff, Kristin M. Sass, Wheelock, M. J., and  Johnson, K. R. J. Cell Biol. 151:1193-120.   49.            Expression of N-cadherin by human squamous carcinoma cells induces a scattered fibroblastic phenotype with disrupted cell-to-cell adhesion. Islam, S., Carey, T. E., Wolf, G. T., Wheelock, M. J., and Johnson, K. R. J. Cell Biol. 135:1643- 1654.

Peer reviewed commentaries from Institute of Quality Management and Healthcare (IQMH) at https://iqmh.org/ (15)      
1.            Summary, discussion of participant performance and educational commentary associated with Cytopathology Proficiency Testing surveys -CYTO-1401. Z. Ghorab, M. Weir, S. Islam, S. McRae and D. Kuni      
2.            Summary, discussion of participant performance and educational commentary associated with Cytopathology Proficiency Testing surveys -CYTO-1405. S. Islam, M. Weir, Z. Ghorab, D. Kuni and S. McRae      
3.            Summary, discussion of participant performance and educational commentary associated with Cytopathology Proficiency Testing surveys -CYTO 1409-PP (patterns-of-practice). M. Weir, S. Islam, Z. Ghorab, D. Kuni and S. McRae       4.            Summary, discussion of participant performance and educational commentary associated with Cytopathology Proficiency Testing surveys-CYTO-1501.  S. Islam, M. Weir, Z. Ghorab, E. Ecobichon-Morris and S. McRae,      
5.            Summary, discussion of participant performance and educational commentary associated with Cytopathology Proficiency Testing surveys -CYTO-1505. S. Islam, M. Weir, Z. Ghorab, E. Ecobichon-Morris and S. McRae,      
6.            Summary, discussion of participant performance and educational commentary associated with Cytopathology Proficiency Testing surveys -CYTO-1601. Z. Ghorab, M. Weir, S. Islam, E. Ecobichon-Morris and S. McRae      
7.            Summary, discussion of participant performance and educational commentary associated with Cytopathology Proficiency Testing surveys -CYTO-1605. S. Islam, M. Weir, Z. Ghorab, E. Ecobichon-Morris and S. McRae      
8.            Summary, discussion of participant performance and educational commentary associated with Cytopathology Proficiency Testing surveys -CYTO-1610-PP (patterns-of-practice). M. Weir, S. Islam, Z. Ghorab, E. Ecobichon-Morris and S. McRae      
9.            Summary, discussion of participant performance and educational commentary associated with Cytopathology Proficiency Testing surveys -CYTO-1701. S. Islam, Z. Ghorab, C.Zeman-Pocrnich, S. McRae, E. Ecobichon-Morris  
10.            Summary, discussion of participant performance and educational commentary associated with Cytopathology Proficiency Testing surveys -CYTO-1705. Z. Ghorab, S. Islam, C.Zeman-Pocrnich, S. McRae, E. Ecobichon-Morris and S. McRae  
11.            Summary, discussion of participant performance and educational commentary associated with Cytopathology Proficiency Testing surveys -CYTO-1801. C. Zeman-Pocrnich, S. Islam, Z. Ghorab, S. McRae, E. Ecobichon-Morris  
12.            Summary, discussion of participant performance and educational commentary associated with Cytopathology Proficiency Testing surveys -CYTO-1805. Z. Ghorab, S. Islam, C.Zeman-Pocrnich, E. Ecobichon-Morris and S. McRae,   13.            Summary, discussion of participant performance and educational commentary associated with Cytopathology Proficiency Testing surveys -CYTO-1809-PP (patterns-of-practice). C.Zeman-Pocrnich, S. Islam, Z. Ghorab, S. McRae, E. Ecobichon-Morris  
14.            Summary, discussion of participant performance and educational commentary associated with Cytopathology Proficiency Testing surveys -CYTO-1901-NG. Z. Ghorab, S. Islam, C.Zeman-Pocrnich, E. Ecobichon-Morris and S. McRae,   15.            Consensus Practice Recommendation – Gynecologic and Non-Gynecologic Cytology, 2015. S. Islam, Z. Ghorab, C.Zeman-Pocrnich, S. McRae, E. Ecobichon-Morris

External Expert Review of Practice Guidelines (8):      
1.            Canadian Society of Cytopathology (CCS) Guidelines for Gynecologic and Non-Gynecologic Cytology      
2.            Best Practice Recommendation Guidelines for Gynecologic and Non-Gynecologic Cytopathology (Institute of Quality Management in Healthcare, IQMH)      3.            Best Practice Recommendation for Standards2Cytology document (an initiative by OMA and CPSO)      
4.            EBS 26-3Evidence-Based Series 26-3IN REVIEWA Quality Initiative of the Program in Evidence-Based Care (PEBC), Cancer Care Ontario (CCO)Follow-up and Surveillance of Curatively Treated Lung Cancer Patients      
5.            Evidence-Based Series #1-19A Quality Initiative of the Program in Evidence-Based Care (PEBC), Cancer Care Ontario (CCO) Locoregional Therapy of Locally Advanced Breast Cancer(LABC)      
6.            Evidence-Based Series #15-12Version 2A Quality Initiative of the Program in Evidence-Based Care (PEBC), Cancer Care Ontario (CCO) The Organization of Colposcopy Services in Ontario: Recommended Framework      
7.            Guideline 4-3 Version 4A Quality Initiative of the Program in Evidence-Based Care (PEBC), Cancer Care Ontario (CCO) Systemic Therapy for Recurrent Epithelial Ovarian Cancer      
8.            Evidence -Based Series #7-13-2v2 Recommendations for Prophylactic Cranial Irradiation and Consolidative Radiation for Patients with Small Cell Lung Cancer: Endorsement: 2019 National Institute for Health and Care Excellence.        9.            Evidence-guideline #7-A-2018-2 Therapy for Stage IV Non-Small Cell Lung Cancer without Driver Alterations: ASCO and CCO Joint Clinical Practice Guideline Update.

Book Chapters (peer reviewed) at http://www.pathologyoutlines.com/ Completed chapters (66):      
1.            Thyroid gland - Bethesda guidelines for cytology: Malignant - 1 Jul 2014       2.            Ovary - nontumor - Hypothyroidism and ovarian cysts - 1 Jun 2012       3.            Ovary - nontumor - Large solitary luteinized follicular cyst of pregnancy and puerperium - 1 Jun 2012      
4.            Ovary - nontumor - Massive edema of ovary - 1 Jun 2012      
5.            Ovary - nontumor - Ovarian pregnancy - 1 Jun 2012      
6.            Ovary - nontumor - Polycystic ovary disease (PCO) - 1 Jun 2012       7.            Ovary - nontumor - Postoperative carbon pigment granuloma - 1 Jun 2012    8.            Ovary - nontumor - Pregnancy luteoma - 1 Jun 2012      
9.            Ovary - nontumor - Rete ovarii cyst - 1 May 2012  
10.            Ovary - nontumor - Splenic gonadal fusion - 1 May 2012  
11.            Ovary - nontumor - Stromal hyperplasia - 1 May 2012  
12.            Ovary - nontumor - Supernumerary ovaries - 1 May 2012  
13.            Ovary - nontumor - Torsion - 1 May 2012  
14.            Ovary - nontumor - Uterus-like mass of ovary - 1 May 2012  
15.            Thyroid gland - Anaplastic carcinoma - Paucicellular variant - 1 Mar 2009   16.            Thyroid gland - Anaplastic carcinoma - rhabdoid variant - 1 Mar 2009   17.            Thyroid gland - Autoimmune thyroiditis - 1 Mar 2009  
18.            Thyroid gland - Clear cell change - 1 Mar 2009  
19.            Thyroid gland - Columnar cell variant - 1 Mar 2009  
20.            Thyroid gland - Cribriform-morular variant - 2 Mar 2009  
21.            Thyroid gland - Cystic ultimobranchial body remnants - 2 Mar 2009   22.            Thyroid gland - Cytology - cytodiagnostic groups - 1 Mar 2009  
23.            Thyroid gland - Diffuse follicular variant - 1 Mar 2009  
24.            Thyroid gland - Diffuse sclerosing variant - 1 Mar 2009  
25.            Thyroid gland - Encapsulated follicular variant - 1 Mar 2009  
26.            Thyroid gland - Encapsulated variant - 1 Mar 2009  
27.            Thyroid gland - FNA tissue effects - 1 Mar 2009  
28.            Thyroid gland - Focal lymphocytic thyroiditis - 1 Mar 2009  
29.            Thyroid gland - Follicular neoplasm - 1 May 2014  
30.            Thyroid gland - Frozen section - 1 Mar 2009  
31.            Thyroid gland - Grossing thyroid specimens - 1 Mar 2009  
32.            Thyroid gland - Hashimoto thyroiditis - 1 Mar 2009  
33.            Thyroid gland - Hashimoto's thyroiditis - Fibrous (fibrosing) variant - 1 Mar 2009  
34.            Thyroid gland - Histology - 1 Mar 2009  
35.            Thyroid gland - Infectious thyroiditis - 1 Mar 2009  
36.            Thyroid gland - Infectious thyroiditis - Tuberculous thyroiditis - 2 Mar 2009   37.            Thyroid gland - Insular carcinoma - Poorly differentiated carcinoma with rhabdoid features - 2 Mar 2009  
38.            Thyroid gland - Lithium thyroiditis - 1 Mar 2009  
39.            Thyroid gland - Macrofollicular variant - 1 Mar 2009  
 40.            Thyroid gland - Microcarcinoma variant - 1 Mar 2009  
41.            Thyroid gland - Mixed medullary-follicular tumors - 1 Mar 2009  
42.            Thyroid gland - Nodular fasciitis-like stroma variant - 1 Mar 2009   43.            Thyroid gland - Normal physiology - 1 Mar 2009  
44.            Thyroid gland - Oncocytic variant - 1 Mar 2009  
45.            Thyroid gland - Palpation thyroiditis - 1 Mar 2009  
46.            Thyroid gland - Papillary carcinoma - follicular variant - 1 Mar 2009   47.            Thyroid gland - Papillary carcinoma - general - 1 Mar 2009  
48.            Thyroid gland - Papillary carcinoma - tall cell variant - 1 Mar 2009   49.            Thyroid gland - Papillary carcinoma in children - 1 Mar 2009  
50.            Thyroid gland - papillary carcinoma: cytology - 1 Mar 2009  
51.            Thyroid gland - Post-partum thyroiditis - 2 Mar 2009  
52.            Thyroid gland - Postoperative necrotizing granulomas - 1 Mar 2009   53.            Thyroid gland - Radiation thyroiditis (radiation induced changes) - 1 Mar 2009  
54.            Thyroid gland - Riedel thyroiditis - 1 Mar 2009  
55.            Thyroid gland - Rosai-Dorfman disease - 1 Mar 2009  
56.            Thyroid gland - SARS related changes - 1 Mar 2009  
 57.           Thyroid gland - Silent thyroiditis - 1 Mar 2009  
 58.           Thyroid gland - Solid variant - 1 Mar 2009  
59.            Thyroid gland - Solitary papillary hyperplastic nodule - 1 Mar 2009   60.            Thyroid gland - Subacute thyroiditis - 1 Mar 2009  
61.            Thyroid gland - Thyroid cancer - General - 1 Mar 2009  
62.            Thyroid gland - Thyroid cancer in children - 1 Mar 2009  
63.            Thyroid gland - Toxic multinodular goiter - 1 Mar 2009  
64.            Thyroid gland - Ultimobranchial body development in thyroid gland - 9 Mar 2009  
65.            Thyroid gland - Variations of normal thyroid gland - 1 Mar 2009  
66.            Thyroid gland - Warthin-like variant - 1 Mar 2009

Diseases, conditions and populations of interest